Search research articles
Contact Us
Filters
Showing results (661-670 of 725) with videos related to
Page
of 73
Sort By:
Islets
|
November 22, 2017
Perinatal exposure to high dietary advanced glycation end products in transgenic NOD8.3 mice leads to pancreatic beta cell dysfunction
Danielle J Borg, Felicia Y T Yap, Sahar Keshvari, et al.
American Journal of Nephrology
|
August 31, 2011
Advanced glycation urinary protein-bound biomarkers and severity of diabetic nephropathy in man
Melinda T Coughlan, Sheila K Patel, George Jerums, et al.
Journal of the American Society of Nephrology : JASN
|
June 3, 2005
Modulation of soluble receptor for advanced glycation end products by angiotensin-converting enzyme-1 inhibition in diabetic nephropathy
Josephine M Forbes, Suzanne R Thorpe, Vicki Thallas-Bonke, et al.
Journal of Hypertension
|
February 27, 2010
Advanced glycation end-products induce vascular dysfunction via resistance to nitric oxide and suppression of endothelial nitric oxide synthase
Aino Soro-Paavonen, Wei-Zeng Zhang, Kylie Venardos, et al.
Archives of Virology
|
January 15, 2026
New parajeilongviruses detected in bats but not in humans: assays for screening and diagnostic purposes
Emilia Pulkkinen, Reilly Jackson, Ruut Joensuu, et al.
Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences
|
March 14, 2018
Food for contagion: synthesis and future directions for studying host-parasite responses to resource shifts in anthropogenic environments
Sonia Altizer, Daniel J Becker, Jonathan H Epstein, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada
|
April 8, 2024
An analysis of benign prostatic hyperplasia surgical treatment reimbursement trends across Canada Examining provincial changes over the recent decade with comparison to cost of living changes
Anindyo Chakraborty, Dean Elterman, Nicholas Corsi, et al.
The Prostate
|
July 21, 2021
The prostaglandin pathway is activated in patients who fail medical therapy for benign prostatic hyperplasia with lower urinary tract symptoms
RenJie Jin, Douglas W Strand, Connor M Forbes, et al.
Clinical Chemistry and Laboratory Medicine
|
March 26, 2013
Plasma advanced glycation end products (AGEs) and NF-κB activity are independent determinants of diastolic and pulse pressure
Karly C Sourris, Jasmine G Lyons, Sonia L Dougherty, et al.
Kidney International
|
May 14, 2010
Circulating high-molecular-weight RAGE ligands activate pathways implicated in the development of diabetic nephropathy
Sally A Penfold, Melinda T Coughlan, Sheila K Patel, et al.
Page
of 73
Search research articles
Search
Showing results (661-670 of 725) with videos related to
Sort By:
Page
of 73
Islets
|
November 22, 2017
Perinatal exposure to high dietary advanced glycation end products in transgenic NOD8.3 mice leads to pancreatic beta cell dysfunction
Danielle J Borg, Felicia Y T Yap, Sahar Keshvari, et al.
American Journal of Nephrology
|
August 31, 2011
Advanced glycation urinary protein-bound biomarkers and severity of diabetic nephropathy in man
Melinda T Coughlan, Sheila K Patel, George Jerums, et al.
Journal of the American Society of Nephrology : JASN
|
June 3, 2005
Modulation of soluble receptor for advanced glycation end products by angiotensin-converting enzyme-1 inhibition in diabetic nephropathy
Josephine M Forbes, Suzanne R Thorpe, Vicki Thallas-Bonke, et al.
Journal of Hypertension
|
February 27, 2010
Advanced glycation end-products induce vascular dysfunction via resistance to nitric oxide and suppression of endothelial nitric oxide synthase
Aino Soro-Paavonen, Wei-Zeng Zhang, Kylie Venardos, et al.
Archives of Virology
|
January 15, 2026
New parajeilongviruses detected in bats but not in humans: assays for screening and diagnostic purposes
Emilia Pulkkinen, Reilly Jackson, Ruut Joensuu, et al.
Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences
|
March 14, 2018
Food for contagion: synthesis and future directions for studying host-parasite responses to resource shifts in anthropogenic environments
Sonia Altizer, Daniel J Becker, Jonathan H Epstein, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada
|
April 8, 2024
An analysis of benign prostatic hyperplasia surgical treatment reimbursement trends across Canada Examining provincial changes over the recent decade with comparison to cost of living changes
Anindyo Chakraborty, Dean Elterman, Nicholas Corsi, et al.
The Prostate
|
July 21, 2021
The prostaglandin pathway is activated in patients who fail medical therapy for benign prostatic hyperplasia with lower urinary tract symptoms
RenJie Jin, Douglas W Strand, Connor M Forbes, et al.
Clinical Chemistry and Laboratory Medicine
|
March 26, 2013
Plasma advanced glycation end products (AGEs) and NF-κB activity are independent determinants of diastolic and pulse pressure
Karly C Sourris, Jasmine G Lyons, Sonia L Dougherty, et al.
Kidney International
|
May 14, 2010
Circulating high-molecular-weight RAGE ligands activate pathways implicated in the development of diabetic nephropathy
Sally A Penfold, Melinda T Coughlan, Sheila K Patel, et al.
Page
of 73